Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 34 citing articles:

HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder
Ke Xu, Mingyang Wang, Haiyang Wang, et al.
Journal of Advanced Research (2023) Vol. 59, pp. 79-96
Open Access | Times Cited: 28
Stattic ameliorates the cecal ligation and puncture-induced cardiac injury in septic mice via IL-6-gp130-STAT3 signaling pathway
Samar Imbaby, Yuichi Hattori
Life Sciences (2023) Vol. 330, pp. 122008-122008
Closed Access | Times Cited: 18
Taurochenodeoxycholic acid reduces astrocytic neuroinflammation and alleviates experimental autoimmune encephalomyelitis in mice
Nuo Xu, Yuyan Bai, Xinyan Han, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152388-152388
Closed Access | Times Cited: 17
Panax notoginseng saponins (PNS) attenuate Th17 cell differentiation in CIA mice via inhibition of nuclear PKM2-mediated STAT3 phosphorylation
Meiyu Shen, Yuxi Di, Xiang Wang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 459-472
Open Access | Times Cited: 15
Dose-Dependent Effect of a New Biotin Compound in Hippocampal Remyelination in Rats
Burak Yuluğ, Ertuğrul Kılıç, Tuba Oğuz, et al.
Molecular Neurobiology (2025)
Open Access
CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery
Haneen A. Al‐Mazroua, Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.
Molecular Immunology (2022) Vol. 144, pp. 127-137
Closed Access | Times Cited: 24
C C chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis
Sheikh F. Ahmad, Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.
Cellular Immunology (2022) Vol. 379, pp. 104580-104580
Closed Access | Times Cited: 22
Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway
Mohamed A. Sadek, Esraa A. Kandil, Nesrine S. El Sayed, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109647-109647
Closed Access | Times Cited: 22
Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108703-108703
Closed Access | Times Cited: 18
S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells
Sheikh F. Ahmad, Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 73, pp. 104658-104658
Closed Access | Times Cited: 11
Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells
Hatun A. Alomar, Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.
Brain Research Bulletin (2023) Vol. 194, pp. 45-53
Open Access | Times Cited: 10
Inhibition of ITK Signaling Causes Amelioration in Sepsis-Associated Neuroinflammation and Depression-like State in Mice
Mohammad Algahtani, Samiyah Alshehri, Sana S. Alqarni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8101-8101
Open Access | Times Cited: 10
Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance
Abdullah A. Aldossari, Mohammed A. Assiri, Mushtaq Ahmad Ansari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15273-15273
Open Access | Times Cited: 9
The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren’s Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data
Xiangxiang Hong, Xin Wang, Xinming Rang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Advances in Immunosuppressive Agents Based on Signal Pathway
Zhiqing Xu, Ming Chu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Sheikh F. Ahmad, Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.
European Journal of Pharmacology (2023) Vol. 959, pp. 176086-176086
Closed Access | Times Cited: 8
STAT3 promotes cytoplasmic-nuclear translocation of RNA-binding protein HuR to inhibit IL-1β-induced IL-8 production
Jiangwen Long, Zhao Wang, Yangen Xiang, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112065-112065
Closed Access | Times Cited: 1
Intraperitoneal injection of mesenchymal stem cells-conditioned media (MSCS-CM) treated monocyte can potentially alleviate motor defects in experimental autoimmune encephalomyelitis female mice; An original experimental study
Bahman Jalali Kondori, Amir Abdolmaleki, Mahdi Raei, et al.
Transplant Immunology (2024) Vol. 85, pp. 102067-102067
Open Access | Times Cited: 1
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study
Abigail Gault, Linda Hogarth, Kristian C. Williams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis
Fang Liu, Moaddey Alfarhan, Leanna Baker, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4100-4100
Open Access | Times Cited: 8
Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE
Layla A. Al‐Kharashi, Naif O. Al‐Harbi, Sheikh F. Ahmad, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2502-2502
Open Access | Times Cited: 4
High-density lipoprotein reduces microglia activation and protects against experimental autoimmune encephalomyelitis in mice
Hong Shan, Min Niu, Dong-Mei Meng, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108566-108566
Closed Access | Times Cited: 7
An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models
Aakanksha Dixit, Hannah S. Savage, Judith M. Greer
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 7, pp. 553-574
Closed Access | Times Cited: 3
Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model
Abdulaziz M.S. Alsaad, Mushtaq Ahmad Ansari, Ahmed Nadeem, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12991-12991
Open Access | Times Cited: 2
Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition
Marcelo Franchin, Pedro Luiz Rosalen, Douglas da Silva Prado, et al.
European Journal of Pharmacology (2022) Vol. 929, pp. 175127-175127
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top